IIT Bombay has developed needle-free shock syringes for painless, safe drug delivery, offering hope for a future without injection-related trauma. Tested on rats, it outperformed traditional needles ...

The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly and Company. Launched in 2022, the collaboration aims to deliver a ...

A fever higher than 100.4 F following an injection warrants immediate medical care. Fevers this high may be due to an infection caused by needle contamination. Fever with chills is especially ...

Orthovisc is considered a medical device, not a drug, as is the case with other hyaluronates used in viscosupplementation. Orthovisc is administered as a series of three or four weekly intra-articular ...

The collaboration of Lilly and EVA Pharma began in 2022 to provide affordable insulin. Credit: © 2022 Eva Pharma All Rights Reserved. Eli Lilly and EVA Pharma have ...

(RTTNews) - Eli Lilly and Company said the Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly (LLY). The ...

The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly (LLY). Launched in 2022, the collaboration aims to deliver a ...

engaged with the local regulatory authorities to obtain approval of the insulin glargine injection, and released the first batch of the locally manufactured insulin drug product. Additionally ...

Less than two years after the initial announcement, EVA Pharma has completed a new biologics manufacturing facility, finalized insulin formulations and stability testing processes, engaged with the ...

Conclusion — A single subcutaneous injection of glargine at a dose of ≥0.5 units/kg can acutely reduce glucose, NEFA, and ketone body levels for 24 h in obese insulin-resistant type 2 diabetic ...